Ubie is a health-tech company globally providing an AI symptom-checker with 10+ million monthly active users, co-founded by a medical doctor and an engineer. We maintain a robust presence in New York, Tokyo, and Singapore, and are honored to be recognized as LinkedIn's fastest-growing startup in Japan for 2021. Ubie's disease prediction AI is renowned for its unparalleled accuracy. This core technology powers our web-based symptom checker that guides over 7 million patients towards better care decisions each month. Our advanced SaaS solutions are trusted by 1500+ healthcare provider organizations, improving triaging, boosting operational efficiency, and supporting clinicians in making informed decisions. We have successfully established strategic business alliances with more than 50% of the world's mega-pharma companies, demonstrating our significant influence within the global healthcare industry. A forward-thinking vision and commitment to improving healthcare have resulted in substantial support from IDEO, complemented by funding from Design for Ventures. Experience Ubie's AI Symptom Checker for yourself: https://ubiehealth.com/
2017
Ubie raised undisclosed on April 6, 2025
Investors: Japan Post Capital